|
US4768523A
(en)
|
1981-04-29 |
1988-09-06 |
Lifecore Biomedical, Inc. |
Hydrogel adhesive
|
|
US4873191A
(en)
|
1981-06-12 |
1989-10-10 |
Ohio University |
Genetic transformation of zygotes
|
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
US4870009A
(en)
|
1982-11-22 |
1989-09-26 |
The Salk Institute For Biological Studies |
Method of obtaining gene product through the generation of transgenic animals
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4736866B1
(en)
|
1984-06-22 |
1988-04-12 |
|
Transgenic non-human mammals
|
|
JPS6147500A
(ja)
|
1984-08-15 |
1986-03-07 |
Res Dev Corp Of Japan |
キメラモノクロ−ナル抗体及びその製造法
|
|
EP0173494A3
(en)
|
1984-08-27 |
1987-11-25 |
The Board Of Trustees Of The Leland Stanford Junior University |
Chimeric receptors by dna splicing and expression
|
|
GB8422238D0
(en)
|
1984-09-03 |
1984-10-10 |
Neuberger M S |
Chimeric proteins
|
|
JPS61134325A
(ja)
|
1984-12-04 |
1986-06-21 |
Teijin Ltd |
ハイブリツド抗体遺伝子の発現方法
|
|
US4733665C2
(en)
|
1985-11-07 |
2002-01-29 |
Expandable Grafts Partnership |
Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
DE122007000007I1
(de)
|
1986-04-09 |
2007-05-16 |
Genzyme Corp |
Genetisch transformierte Tiere, die ein gewünschtes Protein in Milch absondern
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
US5041138A
(en)
|
1986-11-20 |
1991-08-20 |
Massachusetts Institute Of Technology |
Neomorphogenesis of cartilage in vivo from cell culture
|
|
GB8630273D0
(en)
|
1986-12-18 |
1987-01-28 |
Til Medical Ltd |
Pharmaceutical delivery systems
|
|
US5092871A
(en)
|
1987-03-13 |
1992-03-03 |
Brown University Research Foundation |
Electrically-charged nerve guidance channels
|
|
US5041126A
(en)
|
1987-03-13 |
1991-08-20 |
Cook Incorporated |
Endovascular stent and delivery system
|
|
US4873316A
(en)
|
1987-06-23 |
1989-10-10 |
Biogen, Inc. |
Isolation of exogenous recombinant proteins from the milk of transgenic mammals
|
|
US5080891A
(en)
|
1987-08-03 |
1992-01-14 |
Ddi Pharmaceuticals, Inc. |
Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols
|
|
US5213580A
(en)
|
1988-08-24 |
1993-05-25 |
Endoluminal Therapeutics, Inc. |
Biodegradable polymeric endoluminal sealing process
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
US4955892A
(en)
|
1988-10-24 |
1990-09-11 |
Louisiana State University |
Neural cell adhesion protein nerve prosthesis
|
|
US5089606A
(en)
|
1989-01-24 |
1992-02-18 |
Minnesota Mining And Manufacturing Company |
Water-insoluble polysaccharide hydrogel foam for medical applications
|
|
FR2646438B1
(fr)
|
1989-03-20 |
2007-11-02 |
Pasteur Institut |
Procede de remplacement specifique d'une copie d'un gene present dans le genome receveur par l'integration d'un gene different de celui ou se fait l'integration
|
|
US5328470A
(en)
|
1989-03-31 |
1994-07-12 |
The Regents Of The University Of Michigan |
Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
|
|
JPH085780B2
(ja)
|
1989-04-28 |
1996-01-24 |
呉羽化学工業株式会社 |
変形性関節症治療剤
|
|
AU633958B2
(en)
|
1989-07-25 |
1993-02-11 |
Cell Genesys, Inc. |
Homologous recombination for universal donor cells and chimeric mammalian hosts
|
|
US5439446A
(en)
|
1994-06-30 |
1995-08-08 |
Boston Scientific Corporation |
Stent and therapeutic delivery system
|
|
US5052998A
(en)
|
1990-04-04 |
1991-10-01 |
Zimmon David S |
Indwelling stent and method of use
|
|
US5064435A
(en)
|
1990-06-28 |
1991-11-12 |
Schneider (Usa) Inc. |
Self-expanding prosthesis having stable axial length
|
|
US5393788A
(en)
|
1990-07-10 |
1995-02-28 |
Smithkline Beecham Corporation |
Phenylalkyl oxamides
|
|
WO1992013878A2
(en)
|
1991-02-07 |
1992-08-20 |
Board Of Trustees Of The University Of Illinois |
Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same
|
|
WO1992015323A1
(en)
|
1991-03-11 |
1992-09-17 |
Creative Biomolecules, Inc. |
Protein-induced morphogenesis
|
|
US5147370A
(en)
|
1991-06-12 |
1992-09-15 |
Mcnamara Thomas O |
Nitinol stent for hollow body conduits
|
|
WO1993004169A1
(en)
|
1991-08-20 |
1993-03-04 |
Genpharm International, Inc. |
Gene targeting in animal cells using isogenic dna constructs
|
|
DE69233559T2
(de)
|
1991-08-30 |
2006-08-31 |
Curis, Inc., Cambridge |
Osteogenische proteine in der behandlung von metabolischen knochenkrankheiten
|
|
ATE192931T1
(de)
|
1991-08-30 |
2000-06-15 |
Creative Biomolecules Inc |
Morphogen-induzierte modulation von entzündlichen antworten
|
|
US5525519A
(en)
|
1992-01-07 |
1996-06-11 |
Middlesex Sciences, Inc. |
Method for isolating biomolecules from a biological sample with linear polymers
|
|
US5176626A
(en)
|
1992-01-15 |
1993-01-05 |
Wilson-Cook Medical, Inc. |
Indwelling stent
|
|
US5683448A
(en)
|
1992-02-21 |
1997-11-04 |
Boston Scientific Technology, Inc. |
Intraluminal stent and graft
|
|
US5233409A
(en)
|
1992-02-25 |
1993-08-03 |
Schwab Karl W |
Color analysis of organic constituents in sedimentary rocks for thermal maturity
|
|
EP0653942B2
(en)
|
1992-07-31 |
2007-03-07 |
Curis, Inc. |
Morphogen-induced nerve regeneration and repair
|
|
ATE198049T1
(de)
|
1992-09-15 |
2000-12-15 |
Creative Biomolecules Inc |
Behandlung von magen- und darmgeschwüren mit morphogenen
|
|
ES2114073T3
(es)
|
1992-09-16 |
1998-05-16 |
Creative Biomolecules Inc |
Regeneracion del higado inducida por morfogenes.
|
|
EP1362913B1
(en)
|
1992-10-30 |
2006-01-25 |
The General Hospital Corporation |
Interaction trap system for isolating proteins
|
|
KR950704485A
(ko)
|
1992-11-17 |
1995-11-20 |
로이드 제이. 오울드·에드워드 에이, 맥더모 2세 |
액티빈 리셉터-유사 키나제, 세린 트레오닌 키나제 도메인을 갖는 단백질 및 이들의 용도(activin receptor-like kinases, proteins having serine threonine kinase domains and their use)
|
|
US5637480A
(en)
|
1993-05-12 |
1997-06-10 |
Genetics Institute, Inc. |
DNA molecules encoding bone morphogenetic protein-10
|
|
US5579591A
(en)
|
1993-06-29 |
1996-12-03 |
Limited Responsibility Company Frontier |
Footwear for patients of osteoarthritis of the knee
|
|
WO1995018856A1
(en)
|
1993-12-30 |
1995-07-13 |
President And Fellows Of Harvard College |
Vertebrate embryonic pattern-inducing hedgehog-like proteins
|
|
AU702163B2
(en)
|
1994-04-29 |
1999-02-18 |
Creative Biomolecules, Inc. |
Morphogenic protein-specific cell surface receptors and uses therefor
|
|
US5614609A
(en)
|
1994-10-20 |
1997-03-25 |
Carlos F. Ibanez |
Serine threonine kinase receptor
|
|
US6210899B1
(en)
|
1994-11-04 |
2001-04-03 |
The Procter & Gamble Company |
Use of a BMP protein receptor complex for screening bone metabolism actives and cells co-transfected with a type II BMP receptor and type I BMP receptor
|
|
US6306622B1
(en)
|
1994-11-04 |
2001-10-23 |
The Procter & Gamble Co. |
cDNA encoding a BMP type II receptor
|
|
US6281332B1
(en)
|
1994-12-02 |
2001-08-28 |
The Johns Hopkins University School Of Medicine |
Hedgehog-derived polypeptides
|
|
US6485726B1
(en)
|
1995-01-17 |
2002-11-26 |
The Brigham And Women's Hospital, Inc. |
Receptor specific transepithelial transport of therapeutics
|
|
US5681274A
(en)
|
1995-03-31 |
1997-10-28 |
Boston Scientific Corporation |
Variable length uretheral stent
|
|
US5569676A
(en)
|
1995-05-24 |
1996-10-29 |
Diehl; Harry W. |
Method for the treatment of osteoarthritis
|
|
EP0845006A2
(en)
|
1995-08-14 |
1998-06-03 |
Creative Biomolecules, Inc. |
Binding of osteogenic protein-i (op-1) and analogs thereof to the cell surface receptor alk-1 and analogs thereof
|
|
US5989827A
(en)
|
1995-11-14 |
1999-11-23 |
Abbott Laboratories |
Use of nuclear magnetic resonance to design ligands to target biomolecules
|
|
JP2000501744A
(ja)
*
|
1996-01-22 |
2000-02-15 |
クリエイティブ バイオモレキゥルズ，インコーポレーテッド |
モルホゲン類似体およびその製法
|
|
KR20000064752A
(ko)
|
1996-03-22 |
2000-11-06 |
더 제네랄 호스피탈 코포레이션 |
중추신경계허혈또는외상의발현후폴리펩티드성장인자를투여하는방법
|
|
US6376199B1
(en)
|
1997-03-07 |
2002-04-23 |
The Hospital For Sick Children (Hsc) |
Methods to diagnose a required regulation of trophoblast invasion
|
|
US6818440B2
(en)
|
1997-04-28 |
2004-11-16 |
Sugen, Inc. |
Diagnosis and treatment of alk-7 related disorders
|
|
US6111066A
(en)
|
1997-09-02 |
2000-08-29 |
Martek Biosciences Corporation |
Peptidic molecules which have been isotopically substituted with 13 C, 15 N and 2 H in the backbone but not in the sidechains
|
|
US6198281B1
(en)
|
1997-11-12 |
2001-03-06 |
The Research Foundation Of State University Of New York |
NMR spectroscopy of large proteins
|
|
US6194551B1
(en)
|
1998-04-02 |
2001-02-27 |
Genentech, Inc. |
Polypeptide variants
|
|
JP3561738B2
(ja)
|
1998-06-02 |
2004-09-02 |
株式会社リガク |
Ｂｒａｇｇ反射自動選出方法および装置並びに結晶方位自動決定方法およびシステム
|
|
US6800790B2
(en)
|
1998-07-24 |
2004-10-05 |
Carnegie Institution Of Washington |
Method for maintenance and propagation of germline stem cells using members of the TFG-β family of growth factors
|
|
JP2002524528A
(ja)
|
1998-09-11 |
2002-08-06 |
プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ |
ヘッジホッグ様ポリペプチドによる肺組織の調節、およびそれに関する製剤および使用方法
|
|
US6329184B1
(en)
|
1998-12-18 |
2001-12-11 |
Pharmacia & Upjohn Ab |
Crystalline form of activated tartrate-resistant and purple acid phosphatase
|
|
US6444802B1
(en)
|
1999-09-30 |
2002-09-03 |
Millenium Pharmaceuticals, Inc. |
Human aminopeptidase
|
|
US6458387B1
(en)
|
1999-10-18 |
2002-10-01 |
Epic Therapeutics, Inc. |
Sustained release microspheres
|
|
US6468346B2
(en)
|
1999-12-10 |
2002-10-22 |
Bsi Proteomics Corporation |
Applying x-ray topography and diffractometry to improve protein crystal growth
|
|
WO2001064238A2
(en)
|
2000-02-29 |
2001-09-07 |
Curis, Inc. |
Methods and compositions for regulating adipocytes
|
|
US6699278B2
(en)
|
2000-09-22 |
2004-03-02 |
Cordis Corporation |
Stent with optimal strength and radiopacity characteristics
|
|
ES2282163T3
(es)
|
2000-11-06 |
2007-10-16 |
Thrasos, Inc. |
Metodos de escrutinio de mimeticos de morfogenetica osea.
|
|
WO2002037313A2
(en)
|
2000-11-06 |
2002-05-10 |
Thrasos, Inc. |
Computer method and apparatus for classifying objects
|
|
US20040031066A9
(en)
|
2001-01-18 |
2004-02-12 |
Faustman Denise L. |
Mouse model for rheumatoid arthritis
|
|
US6679911B2
(en)
|
2001-03-01 |
2004-01-20 |
Cordis Corporation |
Flexible stent
|
|
EP1383867A2
(en)
|
2001-03-23 |
2004-01-28 |
Axordia Limited |
Stem cell differentiation
|
|
US6673106B2
(en)
|
2001-06-14 |
2004-01-06 |
Cordis Neurovascular, Inc. |
Intravascular stent device
|
|
US20030103959A1
(en)
|
2001-06-22 |
2003-06-05 |
Hughes Paul E. |
Methods of providing neuroprotection and/or neurorestoration via the neural activin type IIB receptor
|
|
WO2003106656A2
(en)
*
|
2002-06-17 |
2003-12-24 |
Thrasos, Inc. |
Single domain tdf-related compounds and analogs thereof
|
|
AU2003276752A1
(en)
*
|
2002-06-17 |
2003-12-31 |
Thrasos, Inc. |
Multiple domain tdf-related compounds and analogs thereof
|
|
JP4971149B2
(ja)
*
|
2004-06-17 |
2012-07-11 |
スラソス セラピューティックス インコーポレーテッド |
Ｔｄｆ関連化合物およびその類似体
|
|
GB0414093D0
(en)
|
2004-06-23 |
2004-07-28 |
Glaxo Group Ltd |
Novel compounds
|
|
US8299212B2
(en)
*
|
2005-09-20 |
2012-10-30 |
Thrasos Therapeutics, Inc. |
TDF-related compounds and analogs thereof, analogs and bioactive fragments
|
|
IT1395574B1
(it)
|
2009-09-14 |
2012-10-16 |
Guala Dispensing Spa |
Dispositivo di erogazione
|